Rise Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Rise Advisors's LLY Position: Q2 2026 in Review
Rise Advisors reduced its Eli Lilly (LLY) stake by 9.9% in Q2 2026, selling an estimated $75.6K and leaving 672 shares worth $806K. The position accounts for 0.23% of the portfolio, ranked #37.
Rise Advisors first reported a position in LLY in Q4 2021 and has held it in 19 quarters since. 4,601 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Rise Advisors held 672 shares of Eli Lilly worth $806K as of Q2 2026.
- Rise Advisors sold 74 Eli Lilly shares in Q2 2026, an estimated $75.6K.
- Eli Lilly made up 0.23% of Rise Advisors's portfolio in Q2 2026, its #37 holding.
- Rise Advisors first reported a position in Eli Lilly in Q4 2021 and has held it in 19 quarters since.
- 4,601 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Rise Advisors's 13F filing for Q2 2026, filed 10 Jul 2026.